Dyne Therapeutics (DYN) Stock: Buy, Sell, or Hold?
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 12, 2026 at $17.19 · last confirmed Nov 13, 2026
Get Alerted When DYN Hits Your Target Price
Join 10,000+ traders who never miss a move
Interactive Price Chart (1 Month)
Loading historical data...
In-depth Analysis How we analyze
Technical Outlook: Technically, DYN is in a strong downtrend. Immediate support is located at $16.42, while resistance sits at $19.00.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.33 (+100.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Trading Range & Key Levels
Protect Your Profits
Holding DYN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanInstitutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research FeedQuantitative Signal Breakdown
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 100.1% below Wall St target ($34.33)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Share this live DYN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DYN)
Data refreshes hourly during market hours. Next update: 5:33 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Is DYN showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$300 | 60 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$595 | 40 SELL |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$469 | 36 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$315 | 39 SELL |
|
KURA
Kura Oncology Inc |
STRONG BUY
16 analysts |
$32 | 63 BUY |
Advanced DYN Option Strategies
Professional options setups generated by AI based on today's DYN price and gamma walls.